Sofinnova Investments’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,302,645
| Closed | -$45.5M | – | 85 |
|
|
2024
Q1 | $45.5M | Buy |
1,302,645
+529,688
| +69% | +$18.5M | 2.54% | 11 |
|
|
2023
Q4 | $29.4M | Buy |
772,957
+29,663
| +4% | +$1.13M | 1.64% | 18 |
|
|
2023
Q3 | $13.6M | Sell |
743,294
-254,989
| -26% | -$4.68M | 0.86% | 29 |
|
|
2023
Q2 | $25.9M | Sell |
998,283
-246,205
| -20% | -$6.39M | 1.7% | 18 |
|
|
2023
Q1 | $23.5M | Buy |
1,244,488
+134,305
| +12% | +$2.53M | 1.5% | 17 |
|
|
2022
Q4 | $27.4M | Buy |
1,110,183
+660,006
| +147% | +$16.3M | 1.62% | 16 |
|
|
2022
Q3 | $8.08M | Buy |
450,177
+302,242
| +204% | +$5.43M | 0.47% | 32 |
|
|
2022
Q2 | $1.68M | Sell |
147,935
-366,705
| -71% | -$4.16M | 0.14% | 48 |
|
|
2022
Q1 | $11.5M | Buy |
514,640
+145,961
| +40% | +$3.25M | 0.87% | 26 |
|
|
2021
Q4 | $16.1M | Buy |
+368,679
| New | +$16.1M | 0.94% | 25 |
|